Showing the single result

  • Placeholder
    In Stock
    Add to wishlist
    Compare
    Quick View
    ,

    Trimetazidine Tablets

    Free

    Product Composition & Strength

    We supply this product as an advanced Modified-Release (MR) Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the stability of both the active ingredient and the kinetic polymer matrix.

    Active IngredientStrengthPrimary Clinical Use
    Trimetazidine Dihydrochloride BP/Ph.Eur.35 mg (Modified-Release)Global Standard: Twice-daily maintenance therapy for stable angina pectoris.
    Trimetazidine Dihydrochloride BP/Ph.Eur.20 mg (Immediate-Release)Three-times-daily dosing for specialized dose titration or specific regional protocols.
    ExcipientsHypromellose (HPMC) / Calcium Hydrogen Phosphate / Magnesium StearateSR Polymer Matrix / Diluent / Lubricant (Engineered for strict 12-hour kinetic release)
    Read more